Molecules belonging to the class of nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit COX2 enzyme, which is involved in inflammation and pain processes. It was found that this enzyme is also involved in the growth of cancer cells. The FDA has approved a drug called “Celebrex” for FAP, a condition that raises the risk of colorectal cancer (see family polyposis).
To check if our service suits your case
We need to talk
Improve therapeutic outcomes, prolong life and quality of life, are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.